Company
Glycologix
A ground-breaking therapy for Interstitial Cystitis / Bladder Pain Syndrome, developing biopolymers for soft tissue repair
Also known as Glycologix, Inc
- Business model
- B2B
- Legal name
- Glycologix, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Developing biopolymers for soft tissue repair
Funding snapshot
- Total raised
- $5.2MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $800K2025-12-12
Funding rounds
- Round, 2025
- $800K2025-12-12, SEC form D sold, 30 investors
- Round, 2024
- $1.5M2024-04-05, SEC form D sold, 48 investors
- Round, 2023
- $1.1M2023-05-15, SEC form D sold, 25 investors
- Round, 2021
- $1.8M2021-12-24, SEC form D sold, 28 investors
Loading relationship preview